Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
Cutaneous and Ocular Toxicology
|
May 4, 2013
Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
Annalisa Patrizi, Michela Venturi, Emi Dika, et al.
Haematologica
|
April 7, 2018
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma
Serena Rocchi, Paola Tacchetti, Lucia Pantani, et al.
Respiratory Medicine
|
April 9, 2017
Respiratory pattern in a FSDH paediatric population
Federica Trucco, Marina Pedemonte, Chiara Fiorillo, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
November 17, 2017
Extramedullary metastatic plasmacytoma in multiple myeloma
Alessandro Pileri, Elena Zamagni, Claudio Agostinelli, et al.
Respiratory Medicine
|
October 4, 2016
Respiratory pattern in a FSHD pediatric population
Federica Trucco, Marina Pedemonte, Chiara Fiorillo, et al.
Cancers
|
May 14, 2025
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
Katia Mancuso, Marco Talarico, Enrica Manzato, et al.
European Journal of Haematology
|
July 13, 2004
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure
Patrizia Tosi, Elena Zamagni, Claudia Cellini, et al.
Expert Review of Hematology
|
October 4, 2021
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients
Paola Tacchetti, Serena Rocchi, Simona Barbato, et al.
Annals of Hematology
|
April 15, 2006
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation
Patrizia Tosi, Elena Zamagni, Delia Cangini, et al.
Expert Review of Anticancer Therapy
|
May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Paola Tacchetti, Marco Talarico, Simona Barbato, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
Cutaneous and Ocular Toxicology
|
May 4, 2013
Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
Annalisa Patrizi, Michela Venturi, Emi Dika, et al.
Haematologica
|
April 7, 2018
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma
Serena Rocchi, Paola Tacchetti, Lucia Pantani, et al.
Respiratory Medicine
|
April 9, 2017
Respiratory pattern in a FSDH paediatric population
Federica Trucco, Marina Pedemonte, Chiara Fiorillo, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
November 17, 2017
Extramedullary metastatic plasmacytoma in multiple myeloma
Alessandro Pileri, Elena Zamagni, Claudio Agostinelli, et al.
Respiratory Medicine
|
October 4, 2016
Respiratory pattern in a FSHD pediatric population
Federica Trucco, Marina Pedemonte, Chiara Fiorillo, et al.
Cancers
|
May 14, 2025
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
Katia Mancuso, Marco Talarico, Enrica Manzato, et al.
European Journal of Haematology
|
July 13, 2004
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure
Patrizia Tosi, Elena Zamagni, Claudia Cellini, et al.
Expert Review of Hematology
|
October 4, 2021
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients
Paola Tacchetti, Serena Rocchi, Simona Barbato, et al.
Annals of Hematology
|
April 15, 2006
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation
Patrizia Tosi, Elena Zamagni, Delia Cangini, et al.
Expert Review of Anticancer Therapy
|
May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Paola Tacchetti, Marco Talarico, Simona Barbato, et al.
Page
of 10